Abstract
The GABAergic system was investigated in C-6 astrocytoma cells and C-1300 neuroblastoma cells in culture and compared to that in mouse brain. The activities of glutamate decarboxylase, GABA-transaminase, succinic semialdehyde dehydrogenase and glutamate dehydrogenase were measured. In the cultured cells, only glutamate dehydrogenase activity was equal or greater than that of mouse cerebral cortex. Glutamate decarboxylase in both cell lines was 2%, while GABA-transaminase and succinic semialdehyde dehydrogenase activities were less than 20% of those found in brain. In spite of the disparate enzyme activities, GABA, glutamate, and α-ketoglutarate concentrations were similar in the cell lines and cerebral cortex. The anticonvulsant drugs sodium valproate and aminooxyacetic acid increased cortical GABA concentrations but either had no effect or decreased GABA in the cells in a complete medium. The convulsant isoniazid decreased GABA in mouse brain but had no effect in either cell line. In the absence of pyridoxal in the medium, some drug effects could be induced in the cultured cells. It is concluded that the differing responses of the GABAergic system in the mouse brain and cell lines may be attributed in part to the fact that the cells do not represent an integrated system and are of tumor origin.
References
Meldrum, B. S. 1975. Epilepsy and γ-aminobutyric acid-mediated inhibition. Pages 1–36,in Pfeiffer, C. C., andSmythies, J. R. (eds.), International Review of Neurobiology, Vol. 17, Academic Press, New York.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., andRandall, R. J. 1951. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193:265–275.
Pitts, F. N., Jr., andQuick, C. 1965. Brain succinate semialdehyde dehydrogenase. 1. Assay and distribution. J. Neurochem. 12:893–900.
Lowry, O. H., andPassonneau, J. V. 1972. Pages 184–185,in A Flexible System of Enzymatic Analysis, Academic Press, New York.
Chude, O., andWu, J.-Y. 1976. A rapid assay technique for brainl-glutamate decarboxylase. Trans. Am. Soc. Neurochem. 7:190.
Lowry, O. H., andCarter, J. G. 1974. Stabilizing the alkali-generated fluorescent derivatives of NAD and NADP. Anal. Biochem. 59:639–642.
Lowe, I. P., Robins, E., andEyerman, G. S. 1958. The fluorimetric measurement of glutamic decarboxylase and its distribution in brain. J. Neurochem. 3:8–18.
Albers, R. W., andBrady, R. O. 1959. The distribution of glutamic decarboxylase in the nervous system of the Rhesus monkey. J. Biol. Chem. 234:926–928.
Pitts, F. N., Jr., Quick, C., andRobins, E. 1965. The enzymic measurement of γ-aminobutyric-α-oxyglutaric transaminase. J. Neurochem. 12:93–101.
Wilson, S. H., Schrier, B. K., Farber, J. L., Thompson, E. J., Rosenberg, R. N., Blume, A. J., andNirenberg, M. W. 1972. Markers for gene expression in cultured cells from the nervous system. J. Biol. Chem. 247:3159–3169.
Hutchinson, H. T., Werrbach, K., Vance, C., andHaber, B. 1974. Uptake of neurotransmitter by clonal lines of astrocytoma and neuroblastoma in culture. I. Transport of γ-aminobutyric acid. Brain Res. 66:265–274.
Hess, W. H., Nahrwold, M. L., andBethell, D. R. 1976. Effects of halothane on γ-aminobutyric acid levels in C-6 and C-1300 cells. Trans. Am. Soc. Neurochem. 7:121.
Wallach, D. P. 1960. Studies on the GABA pathway. I. The inhibition of γ-aminobutyric acid-α-ketoglutaric acid transaminasein vitro andin vivo by U-7524 (amino-oxyacetic acid). Biochem. Pharmacol. 5:323–331.
Baxter, C. F., andRoberts, E. 1961. Elevation of γ-aminobutyric acid in brain: Selective inhibition of γ-aminobutyric-α-ketoglutaric acid transaminase. J. Biol. Chem. 236:3287–3294.
DaVanzo, J. P., Greig, M. E., andCronin, M. A. 1961. Anticonvulsant properties of amino-oxyacetic acid. Am. J. Physiol. 201:833–837.
Kuriyama, K., Roberts, E., andRubenstein, M. K. 1966. Elevation of γ-aminobutyric acid in brain with amino-oxyacetic acid and susceptibility to convulsive seizures in mice: A quantitative reevaluation. Biochem. Pharmacol. 15:221–236.
Meldrum, B. S., Balzano, E., Gadea, M., andNaquet, R. 1970. Photic and drug induced epilepsy in the baboon (Papio papio): The effects of isoniazid, thiosemicarbazide, pyridoxine, and amino-oxyacetic acid. Electroencephalogr. Clin. Neurophysiol. 29:333–347.
Tower, D. B. 1976. GABA and Seizures: Clinical correlates in man. Pages 461–478,in Roberts, E., Chase, T. N., andTower, D. B. (eds.), GABA in Nervous System Function, Raven Press, New York.
Wood, J. D., andPesker, S. J. 1975. The anticonvulsant action of GABA-elevating agents: A reevaluation. J. Neurochem. 25:277–282.
Lust, W. D., Kupferberg, H. J., Passonneau, J. V., andPenry, J. K. 1976. On the mechanism of action of sodium valproate: The relationship of GABA and cyclic GMP levels to anticonvulsant activity. Pages 123–129,in Legg, N. J. (ed), Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, Medical Congresses and Symposia Consultants, Tunbridge Wells, England.
Roberts, E., andSimonsen, D. G. 1963. Some properties ofl-glutamate decarboxylase in mouse brain. Biochem. Pharmacol. 12:113–134.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Passonneau, J.V., Lust, W.D. & Crites, S.K. Studies on the GABAergic system in astrocytoma and neuroblastoma cells in culture. Neurochem Res 2, 605–617 (1977). https://doi.org/10.1007/BF00963775
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00963775